Wednesday, 26 October 2016
Abano Healthcare Group Limited Ordinary Shares
Shareholders passed all resolutions at the 2016 Abano Annual Meeting.
Voting numbers for resolutions 3 and 4 were previously transposed and are now
amended as per the table below.
1. Authorise Directors'' to fix the auditor''s remuneration
FOR 11,310,012 AGAINST 0 ABSTAIN 28,254
2. Election of Dr Ginni Mansberg
FOR 7,228,960 AGAINST 225 ABSTAIN 4,109,081
3. Re-election of Mr Trevor Janes
FOR 7,194,751 AGAINST 4,109,080 ABSTAIN 34, more»
ABANO HEALTHCARE GROUP 2016 ANNUAL MEETING
Business Update and FY17 First Half Guidance
Growth of Abano''s trans-Tasman dental group is driving an uplift in earnings
and profit, despite the sale of the audiology business in June 2016,
shareholders were told at the Abano Healthcare Group Limited (NZX: ABA)
annual meeting held in Auckland today.
Abano is expecting an increase of at least 35% in underlying NPAT from
continuing businesses more»
The Abano Healthcare Group Annual Meeting is being held today in Auckland.
A business update and guidance for the first half of the 2017 financial year
are being provided at the meeting. The company has provided a copy of the
Chairman and Management speeches and presentation.
End CA:00291400 For:ABA Type:ADDRESS Time:2016-10-25 11:29:49 more»
Abano Healthcare Group''s Annual Meeting of Shareholders will be held on
Tuesday 25 October 2016, commencing at 11.30am in the Pakuranga Hunt Room,
Ellerslie Event Centre, 80-100 Ascot Avenue,
Attached are the Notice of Meeting, Letter from the Chairman and Proxy/Voting
form, which are being sent to shareholders today. These will also be
available on the Abano website www.abanohealthcare.co.nz/annualmeeting.
For the purposes of NZX Listing Rule 3.3.5, Abano Healthcare Group Limited
advises that the closing date for director nominations is Monday 12 September
2016. All nominations must be received by 4.00 pm on the closing date.
Nominations may only be made by a shareholder entitled to attend and vote at
the Annual Meeting, and must be accompanied by the consent in writing of the
Nominations should be addressed to:
Abano has provided ongoing disclosure notices for the following Abano
directors and management:
Ted van Arkel
End CA:00287978 For:ABA Type:RELINT Time:2016-08-26 11:25:07 more»
Abano Healthcare Group is presenting to institutional investors in Australia
today. A copy of the presentation is attached.
End CA:00287840 For:ABA Type:ADDRESS Time:2016-08-25 08:32:20 more»
Disclosure of movement of 1% or more in substantial holding
or change in nature of relevant interest, or both
Sections 277 and 278, Financial Markets Conduct Act 2013
Note: This form must be completed in accordance with the instructions at the
end of the form.
To New Zealand Exchange
To Abano Healthcare Group Ltd
Relevant event being disclosed: Movement of 1% or more in the substantial
Date of relevant event: 22 Augu more»
Abano Healthcare Group (NZX:ABA) has today announced the appointment of Dr
Ginni Mansberg as an independent director effective from 24 August 2016.
Dr Mansberg is a Sydney-based GP with a successful clinical practice. She is
a member of the Australian Institute of Company Directors and sits on a
number of corporate and not for profit Advisory Boards, including the
Australian Cervical Cancer Foundation, and the Australian Immunization
NOTICE PURSUANT TO LISTING RULE 7.12.1
22 August 2016
To: NZX Limited
For the purposes of NZX Main Board Listing Rule 7.12.1, Abano Healthcare
Group Limited advises the following in respect of the issue of new ordinary
Listing Rule 7.12.1
(a) Class of Security and ISIN: Fully paid ordinary shares.
(b) Number issued: 194,282 ordinary shares
(c) Nominal value/issue prices: $1,571,7 more»